Mission and Vision
Our Mission
PapEasy’s mission is to help modernize cervical cancer screening through women-centered medical device innovation that improves comfort, access, privacy, and equity across diverse care settings.
Our Vision
PapEasy’s vision is a world where cervical cancer screening is more accessible, more dignified, and more effective for all women, especially those affected by inequality, limited access, and underserved health systems.
Our Commitment
PapEasy is driven by the belief that earlier access to screening can help save lives. Our work is centered on reducing preventable barriers in women’s healthcare and helping expand access to more modern screening solutions for women across communities, geographies, and care environments.
PapEasy History & Journey
PapEasy was founded with a clear mission—to improve access to cervical cancer screening for women worldwide. From the beginning, the focus has been on rethinking traditional screening methods and creating a more comfortable, accessible, and patient-centered experience.
Our Journey So Far
A Mission-Driven Start
PapEasy began with the goal of removing barriers that prevent women from accessing timely cervical cancer screening.
Reimagining the Screening Experience
The PapEasy concept was developed as a speculum-free, non-invasive solution designed to reduce discomfort and improve overall patient experience.
Innovating Through Technology
Early prototype development focused on integrating advanced imaging technology alongside swab-based sample collection to create a more efficient and user-friendly approach.
Listening to Women Globally
Through research initiatives and survey outreach, PapEasy gathered critical insights into the real challenges women face when it comes to screening—across different regions and healthcare environments.
Designing for Accessibility and Privacy
Ongoing innovation has remained centered on making screening more accessible, private, and comfortable for women in all care settings.
Building the Future of Screening
PapEasy continues to expand partnerships, advance research efforts, and move toward future commercialization—bringing its vision of modern cervical cancer screening closer to reality.